Correlation Between Leap Therapeutics and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Leap Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Entero Therapeutics,.

Diversification Opportunities for Leap Therapeutics and Entero Therapeutics,

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Leap and Entero is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Leap Therapeutics and Entero Therapeutics,

Given the investment horizon of 90 days Leap Therapeutics is expected to generate 1.03 times less return on investment than Entero Therapeutics,. In addition to that, Leap Therapeutics is 1.15 times more volatile than Entero Therapeutics,. It trades about 0.14 of its total potential returns per unit of risk. Entero Therapeutics, is currently generating about 0.16 per unit of volatility. If you would invest  184.00  in Entero Therapeutics, on August 14, 2025 and sell it today you would earn a total of  189.00  from holding Entero Therapeutics, or generate 102.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Leap Therapeutics  vs.  Entero Therapeutics,

 Performance 
       Timeline  
Leap Therapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Leap Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Leap Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Entero Therapeutics, 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

Leap Therapeutics and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Leap Therapeutics and Entero Therapeutics,

The main advantage of trading using opposite Leap Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind Leap Therapeutics and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like